24-Norursodeoxycholic acid
Nor-UDCA, a side chain-shortened derivative of ursodeoxycholic acid (UDCA), exhibits enhanced anti-cholestatic, anti-inflammatory, and anti-fibrotic activities. It demonstrates superior efficacy to UDCA in murine models of sclerosing cholangitis, such as Mdr2 knockout mice, making it a valuable research tool for investigating cholestatic liver diseases.
Product Specifications
CAS Number
99697-24-2
Product Name Alternative
Inhibit, Norucholic acid, nor-UDCA, Inhibitor, 24 Norursodeoxycholic acid, 24Norursodeoxycholic acid, 24-Norursodeoxycholic acid
Purity
99.69% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (10.57 mM) ; DMSO:100 mg/mL (264.17 mM)
Smiles
[H][C@@]12CC[C@H] ([C@H] (C) CC (O) =O) [C@@]1 (C) CC[C@@]1 ([H]) [C@@]2 ([H]) [C@@H] (O) C[C@]2 ([H]) C[C@H] (O) CC[C@]12C
Molecular Formula
C23H38O4
Molecular Weight
378.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PE-Linked Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)